Neuropathy Clinical Trial
Official title:
Randomized Double-Blind Study of the Efficacy of Near Infrared Phototherapy on Sensation and Pain in Type 2 Diabetic Neuropathy
This is a double blind, randomized, placebo-controlled study in which a total of 120 patients will be selected from a broad spectrum group of typical Americans (all demographics including various races and both genders as well as ages from 25-90) who have confirmed Type 2 Diabetes Mellitus and suffer from mild to moderate lower extremity Peripheral Neuropathy. All patients will meet inclusion and/or exclusion criteria.
This is a double blind, randomized, placebo-controlled study in which a total of 120
patients will be selected from a broad spectrum group of typical Americans (all demographics
including various races and both genders as well as ages from 25-90) who have confirmed Type
2 Diabetes Mellitus and suffer from mild to moderate lower extremity Peripheral Neuropathy.
All patients will meet inclusion and/or exclusion criteria.
Randomization and Application of HL Device The placebo controlled group of 60 patients will
be randomized from the group of 120 patients by one designee who selects the placebo vs
treatment groups based on acceptable statistical standards for determining placebo vs
treatment arms of research studies. There will be two different HL Devices. There will be
the HL-NIR device that includes NIR diodes and performs Near Infrared therapy and an
identical appearing second device, the HL-SHAM device, that is used as the placebo device
and although appearance is identical, this device does not perform Near Infrared treatment.
Both placebo group and treatment group subjects will have the NIR or sham device applied to
both lower extremities for a short duration three times a week over the course of several
weeks.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03195868 -
Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy
|
N/A | |
| Not yet recruiting |
NCT05565469 -
Correlation Between Abdominal Wall Stimulation and Neurostimulator Tip Location
|
N/A | |
| Completed |
NCT02309164 -
The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).
|
N/A | |
| Completed |
NCT00775645 -
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
|
Phase 3 | |
| Completed |
NCT03624426 -
Detection and Prevention of Nerve Injury in Shoulder Arthroplasty Surgery
|
N/A | |
| Withdrawn |
NCT03436680 -
Home-Based Neurofeedback Program in Treating Participants With Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
| Completed |
NCT05691738 -
Effects of Modified Otago Exercises in Individuals With Diabetic Neuropathy
|
N/A | |
| Completed |
NCT05095870 -
Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
|
||
| Completed |
NCT02615678 -
Acupuncture for CIPN in Breast Cancer Patients
|
N/A | |
| Completed |
NCT02011282 -
Electro-Neuro-Muscular Stimulation in ICU
|
N/A | |
| Recruiting |
NCT01774058 -
The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation
|
Phase 2 | |
| Completed |
NCT01135251 -
Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy
|
Phase 2 | |
| Recruiting |
NCT06324344 -
Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN)
|
N/A | |
| Recruiting |
NCT04403802 -
Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
| Recruiting |
NCT04579406 -
Perioperative Adverse Cardiovascular Event in Type-2 Diabetic Patients
|
||
| Recruiting |
NCT03881930 -
Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy
|
N/A | |
| Completed |
NCT03909464 -
Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy
|
||
| Completed |
NCT01523132 -
Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms
|
N/A | |
| Completed |
NCT02689661 -
Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects
|
||
| Terminated |
NCT00998738 -
Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
|
Phase 3 |